Abstract:We transfected a recombinant plasmid that co-expressed swine ubiquitin and a codon optimized GP5 encoding-gene of porcine reproductive and respiratory syndrome virus (PRRSV), designated pCA-U-optiGP5, as well as the plasmid pCA-optiGP5 encoding codon optimized GP5, and the plasmid pCA-GP5 expressing wild-type pGP5 into 293T cells. Expression of GP5 was measured by indirect immunofluorescence (IIF) assay and Western blot and found to be considerably higher in response to pCA-U-optiGP5 than the wild-type vector. GP5 protein was rapidly degraded in pCA-U-optiGP5-transfected 293T cells. The proteasome inhibitor, MG-132, however, successfully inhibited degradation. Immunogenicity of the three constructs was examined by measuring GP5-specific antibody production, lymphocyte proliferation, cytotoxic T lymphocyte (CTL) responses, and cytokine secretion in intramuscularly immunized pigs. Three weeks after the last inoculation, all animals were challenged intranasally with 2-ml 10(5)TCID(50)/ml PRRSV CH-1a. DNA immunization with pCA-optiGP5 produced a higher level of GP5-specific antibody than immunization with pCA-GP5, and the humoral response remained undetectable in the pCA-U-optiGP5 group. However, the fusion DNA had a significantly enhanced stimulation index (SI) and induced a stronger Th1 type cellular immune response than the single gene DNA, suggesting that ubiquitin conjugation improved the cellular but not the humoral immune response. Four of six pigs in the pCA-U-optiGP5 group, three of six in the pCA-optiGP5 group, and two of six in the pCA-GP5 group were devoid of visible pathological changes that were present in other vaccinated and control animals after challenge. Viral replication and distribution in the blood and tissues was lower in the pCA-U-optiGP5 vaccinated group than the other groups, suggesting that codon optimization, along with the development of rapidly processed antigen, represents a novel strategy to increase the immune efficacy of DNA vaccines against PRRSV.

Effects of DNA recombinant plasmids against porcine reproductive and respiratory syndrome on immunity in pigs

Immunization in Pigs Vaccined with DNA Encoding PRRSV GP5

Positive effects of porcine IL-2 and IL-4 on virus-specific immune responses induced by the porcine reproductive and respiratory syndrome virus (PRRSV) ORF5 DNA vaccine in swine

Immunological evaluation of recombination PRRSV GP3 and GP5 DNA vaccines <i>in vivo</i>

Immunological evaluation of recombination PRRSV GP3 and GP5 DNA vaccines in vivo

Immune Responses in Pigs Induced by Recombinant DNA Vaccine Co-Expressing Swine IL-18 and Membrane Protein of Porcine Reproductive and Respiratory Syndrome Virus.

A Recombinant Plasmid Co-Expressing Swine Ubiquitin and the GP5 Encoding-Gene of Porcine Reproductive and Respiratory Syndrome Virus Induces Protective Immunity in Piglets.

Positive inductive effect of IL-18 on virus-specific immune responses induced by PRRSV-GP5 DNA vaccine in swine

Study on Immunological Responses to Porcine Reproductive and Respiratory Syndrome Virus DNA Vaccines Co-expressing Modified GP5 (gp5m) and M Proteins

Highly Efficient Expression of Interleukin-2 under the Control of Rabbit Beta-Globin Intron Ii Gene Enhances Protective Immune Responses of Porcine Reproductive and Respiratory Syndrome (prrs) Dna Vaccine in Pigs

Cellular immune responses of piglets immunized with different dosage of PRRSV ORF5 gene vaccine by intramuscular injection

Immunization of mice with recombinant DNA vaccines encoding PRRSV GP5 gene

Porcine GPX1 enhances GP5-based DNA vaccination against porcine reproductive and respiratory syndrome virus

Effects of Specific IgY Antibodies Against PRRSV and PCV-2-Cap Protein on Growth Performance and Immunity of Weaning Piglets

Enhanced immunogenicity of the modified GP5 of porcine reproductive and respiratory syndrome virus

Immunogenicity and Protective Efficacy of Recombinant Pseudorabies Virus Expressing the Two Major Membrane-Associated Proteins of Porcine Reproductive and Respiratory Syndrome Virus

Construction and Immunogenicity of DNA Vaccines Encoding Fusion Protein of Porcine IFN- Λ 1 and GP5 Gene of Porcine Reproductive and Respiratory Syndrome Virus.

The co-administrating of recombinant porcine IL-2 could enhance protective immune responses to PRV inactivated vaccine in pigs.

Immune Responses of Pigs Immunized with a Recombinant Porcine Reproductive and Respiratory Syndrome Virus Expressing Porcine GM-CSF.

Enhancing immunogenicity and antiviral protection of inactivated porcine reproductive and respiratory syndrome virus vaccine in piglets

Construction of Pig IL-2 Eukaryotic Expression Plasmid Pcdna-Il-2 and Its Adjuvant Effect on Pcdna-Prrsv-sc2-orf5 Gene Vaccine